AtriCure Inc

A5I

Company Profile

  • Business description

    AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

  • Contact

    7555 Innovation Way
    MasonOH45040
    USA

    T: +1 513 755-4100

    E: [email protected]

    https://www.atricure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    1,350

Stocks News & Analysis

stocks

This ASX miner is the cheapest in our iron ore coverage

High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks

Apple names new CEO as Tim Cook steps aside after 15 years

John Ternus, Apple’s hardware chief, will take up the role in September.
stocks

Updating our commodity price assumptions

Our view as China’s steel production drops.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,074.4050.80-0.56%
CAC 408,156.4379.28-0.96%
DAX 4024,194.9075.97-0.31%
Dow JONES (US)49,490.03340.650.69%
FTSE 10010,476.4621.63-0.21%
HKSE26,163.24324.24-1.22%
NASDAQ24,657.57397.601.64%
Nikkei 22559,585.86236.690.40%
NZX 50 Index12,945.6013.270.10%
S&P 5007,137.9073.891.05%
S&P/ASX 2008,843.6053.20-0.60%
SSE Composite Index4,106.2621.180.52%

Market Movers